1983- 1989, attending physician of Beiman Special Steel Workers Hospital, director of the president's office.
1989- 1995, business manager of Singapore kaicheng pharmaceutical group.
1995- 1998, sales manager of Shandong luye group.
1998-200 1 year, general manager of Hebei Yiling pharmaceutical group.
200 1 Up to now, he has served as vice president of Buchang Group and chairman of Dezhou Deyao Co., Ltd.
He has successively won the honorary titles of National Advanced Worker in Corporate Culture Construction, China Confucius Award for Corporate Culture, Marketing Award, Marketing Director of Top Ten Famous Enterprises, Top 100 Professional Managers in China and Top 10 Outstanding Professional Managers in China. Obtained two national patents and published more than 20 papers.
He is also the vice chairman of the World Chinese Business Association, a visiting professor at the World Outstanding Chinese Business College, an adjunct professor at Northwest University, and the executive vice president of Shaanxi International Business School.
200 1, as the executive vice president of Buchang Group, mainly responsible for the sales and personnel administration of the Group. Under his leadership, Buchang Group has made remarkable achievements in all its work. Buchang Naoxintong, the main product of the group, won the honor of "the first choice brand for consumers in cardiovascular and cerebrovascular drugs market". Buchang Group has been rated as the largest taxpayer of private enterprises in Shaanxi Province for many years, paying more than 600 million yuan for the country. In 2002, Buchang Group ranked sixth in the income growth rate of non-listed private enterprises in China. From June 5th to February, 2002, Buchang Group was awarded as "Honest Tax Paying Enterprise" by State Taxation Administration of The People's Republic of China, People's Republic of China (PRC) and All-China Federation of Industry and Commerce. In 2003, it ranked seventh among the top ten taxpayers of Chinese herbal pieces enterprises in China. On May 15, 2006, Medical Economic News published "Top 100 Pharmaceutical Industries in China in 2005 (including commerce)", and Buchang Group ranked 3 1 in the list of Top 100 Pharmaceutical Industries in China.
In years of marketing management and actual combat, he pays attention to building an efficient, pragmatic and enterprising enterprise team with culture as a weapon, brand building as the leading factor and human resources promotion as the basis. It has served many domestic private pharmaceutical enterprises for more than 1 billion yuan, and successfully operated several single products for more than 1 billion yuan. Created a marketing model of professional promotion of medicine in China, and cast a diversified marketing team. Now he leads the ten business divisions of Buchang Group to strive for the goal of modernization and internationalization of the Chinese medicine market, which is a century-old step.
Joined CSI Wanrong Investment Company at the end of 2009. Officially entered wohua pharmaceutical technology co., ltd.